Markus Arvendell

Urology resident at Södersjukhuset and PhD student at the Department of Molecular Medicine and Surgery at Karolinska Institute. Specific interest in prostate cancer diagnostics and treatment. The aim of my thesis is to evaluate parts of the ongoing Organised Prostate Cancer Testing (OPT) project in Region Stockholm/Gotland. As part of this, I am a member of the regional OPT research group.
M.D. License to practice medicine since 2022.

My research journey started with evaluating men on hormonal treatment for prostate cancer, resulting in my first publication "Sequential Treatment with Abiraterone and Enzalutamide in Swedish patients with Metastatic Castration-Resistant Prostate Cancer" in Universal Journal of Oncology, December 2020. Since February 2023 I have been pursuing my PhD at the Department of Molecular Medicine and Surgery, Karolinska Institute. My PhD projects aim to evaluate the implementation of the ongoing Organised Prostate Cancer Testing project in Region Stockholm/Gotland, for which my principal supervisor Anna Lantz is the medically responsible doctor.